News

Chemical modifications that appear on some RNA transcripts may have evolved in part to help cells repair themselves after damage, and may also be a key to understanding important human diseases, according to new research from scientists at Weill Cornell Medicine and Cornell’s Ithaca campus.

Awards, honors, prizes and achievements for the month of July.

Dr. Sheila Nirenberg, the Nanette Laitman Professor in Neurology and Neuroscience and a professor of physiology and biophysics at Weill Cornell Medicine, has been named one of Crain’s inaugural Notable Women in Technology in the Greater New York City area.

Dr. Lewis Cantley has been awarded a grant from the Gray Foundation to study the genetic mutations that can lead to breast and ovarian cancer, investigating how early-stage precancerous cells can be recognized by the immune system and targeted with preventive or therapeutic cancer vaccines.

NewYork-Presbyterian Hospital is ranked No. 5 in the nation and No. 1 in New York, according to U.S. News and World Report’s annual survey of “Best Hospitals,” published online today. 

Idiopathic pulmonary fibrosis (IPF), a fatal lung disease whose cause has long been a mystery, may be triggered by damage to mitochondria, the tiny oxygen-burning reactors that provide most of a cell’s energy needs, according to a study from scientists at Weill Cornell Medicine.

Dr. Michael G. Stewart, vice dean and chairman of the Department of Otolaryngology-Head and Neck Surgery at Weill Cornell Medicine, has been appointed the executive vice president of the American Rhinologic Society (ARS).

A molecule best known for its association with migraines may be a key to new treatments for common worm infections as well as allergic inflammatory disorders such as asthma, according to a study from scientists at Weill Cornell Medicine and the National Institutes of Health.

NewYork-Presbyterian and Weill Cornell Medicine have received a grant for more than $2 million from the New York State Office of Victims Services to sustain and grow an innovative emergency department-based program that improves care for victims of elder abuse.

Dr. Juan Cubillos-Ruiz got his first look at ovarian cancer early in his doctoral research, which focused on understanding how the microenvironment of a tumor affects a patient’s immune system. 

HIV epidemics are emerging and growing among female sex workers and their male clients in multiple countries in the Middle East and North Africa, and few of these epidemics have already reached their peak.

A molecular pathway known for responding to cellular stress also produces pain-inducing molecules in immune cells, according to a new study by scientists at Weill Cornell Medicine, Dana-Farber Cancer Institute, Harvard Medical School and Wake Forest University School of Medicine.

Dr. Mary E. Choi, a professor of medicine at Weill Cornell Medicine, has been elected president of the Korean American Medical Association (KAMA).

Northwestern professor Dr. Ricardo Rosenkranz taps his passion for magic to help his students become better doctors

Dr. Lawrence Casalino, chief of the Division of Health Policy and Economics in the Department of Healthcare Policy and Research, and the Livingston Farrand Professor of Public Health at Weill Cornell Medicine, has been appointed to the Medicare Payment Advisory Commission (MedPAC) by the U.S. Government Accountability Office.

Two molecular signaling pathways underlie the cardiac defects associated with one type of the inherited disorder Noonan syndrome (NS), researchers from Masonic Medical Research Institute, Beth Israel Deaconess Medical Center and Weill Cornell Medicine find in a new study.

Matthew Laghezza, chief physician assistant in the Department of Emergency Medicine at Weill Cornell Medicine and the Lisa Perry Emergency Center at NewYork-Presbyterian/Weill Cornell Medical Center, was named 2018 Emergency Medicine Physician Assistant of the Year by the Society of Emergency Medicine Physician Assistants.

The Weill Cornell Graduate School of Medical Sciences has been awarded a competitive grant from the National Institutes of Health to launch a program dedicated to increasing the number and enhancing the success of doctoral students from underrepresented backgrounds.

A newly available drug may improve the effectiveness of immunotherapy in hard-to-treat cancers of the upper urinary tract, suggests a study published by Weill Cornell Medicine and NewYork-Presbyterian investigators.

A new study published July 8 in the Annals of Internal Medicine demonstrates that pregnancy outcomes in the last two decades have drastically improved for patients with systemic lupus erythematosus.